VivoSim Labs (VIVS) Amortizatization of Intangibles (2011 - 2012)
VivoSim Labs (VIVS) posted quarterly Amortizatization of Intangibles of $33.0 for Q4 2012, down 100.0% year-over-year from $1.1 million in Q1 2012, and down 100.0% quarter-over-quarter from $896000.0 in Q1 2012.
VivoSim Labs (VIVS) Amortizatization of Intangibles (2011 - 2012) Analysis & Trends
VivoSim Labs' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $33.0 for Q4 2012.
- In Q4 2012, Amortizatization of Intangibles fell 100.0% year-over-year to $33.0; the TTM figure through Dec 2012 stood at $896033.0 (changed N/A YoY), while the FY2012 annual figure was $896200.0, down 24.56% from the prior year.
- Amortizatization of Intangibles for Q4 2012 stood at $33.0, down from $896000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.1 million in Q4 2011, with the low at $33.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 33.00 |
| Dec 31, 2012 | 33.00 |
| Mar 31, 2012 | 896,000.00 |
| Mar 31, 2012 | 896,000.00 |
| Dec 31, 2011 | 1.09 Mn |
| Dec 31, 2011 | 1.09 Mn |
| Sep 30, 2011 | 1.09 Mn |
| Sep 30, 2011 | 1.09 Mn |
| Jun 30, 2011 | 1.09 Mn |
| Jun 30, 2011 | 1.09 Mn |